Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Coffee Consumption and Risk of Adverse Outcomes

Coffee Consumption and Risk of Adverse Outcomes Letters of kidney outcomes: emulation of a target trial using health care databases. justed for differences in age and clinical risk. On average, Black Diabetes Care. 2020;43(11):2859-2869. doi:10.2337/dc20-1890 participants were 5 years younger than White participants (mean age [SD], 59.8 [10.1] years vs 65.0 [10.5] years, respec- tively). Owing to the difference in age, Black participants were healthier than White participants; Black and White partici- To the Editor I read with interest the article on the association pants had a mean (SD) estimated glomerular filtration rate of of coffee consumption with reduced risk of arrhythmias. In 87.26 (21.71) and 78.31 (18.86) mL/min/1.73m , respectively. agreement with Goldberger and Hayward, I suggest that cau- Rates of cardiovascular disease were 14.87% and 26.27% among tion is needed when interpreting these findings. Concluding Black and White participants, respectively. Rates of conges- that coffee is safe without distinguishing between forms and tive heart failure were 5.10% and 6.30% among Black and White preparations of coffee may be misleading, and it may encour- participants, respectively. age patients to drink as much coffee as they wish. Compared with sulfonylureas, SGLT2 inhibitor use was as- Kim and colleagues did not discuss different types of sociated with http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

Coffee Consumption and Risk of Adverse Outcomes

JAMA Internal Medicine , Volume 182 (1) – Jan 29, 2022

Loading next page...
 
/lp/american-medical-association/coffee-consumption-and-risk-of-adverse-outcomes-gaNx0pGi07

References (10)

Publisher
American Medical Association
Copyright
Copyright 2021 American Medical Association. All Rights Reserved.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/jamainternmed.2021.6920
Publisher site
See Article on Publisher Site

Abstract

Letters of kidney outcomes: emulation of a target trial using health care databases. justed for differences in age and clinical risk. On average, Black Diabetes Care. 2020;43(11):2859-2869. doi:10.2337/dc20-1890 participants were 5 years younger than White participants (mean age [SD], 59.8 [10.1] years vs 65.0 [10.5] years, respec- tively). Owing to the difference in age, Black participants were healthier than White participants; Black and White partici- To the Editor I read with interest the article on the association pants had a mean (SD) estimated glomerular filtration rate of of coffee consumption with reduced risk of arrhythmias. In 87.26 (21.71) and 78.31 (18.86) mL/min/1.73m , respectively. agreement with Goldberger and Hayward, I suggest that cau- Rates of cardiovascular disease were 14.87% and 26.27% among tion is needed when interpreting these findings. Concluding Black and White participants, respectively. Rates of conges- that coffee is safe without distinguishing between forms and tive heart failure were 5.10% and 6.30% among Black and White preparations of coffee may be misleading, and it may encour- participants, respectively. age patients to drink as much coffee as they wish. Compared with sulfonylureas, SGLT2 inhibitor use was as- Kim and colleagues did not discuss different types of sociated with

Journal

JAMA Internal MedicineAmerican Medical Association

Published: Jan 29, 2022

There are no references for this article.